CRSP Earnings:
* Mon 9-NOV-2026
End of day quotes updated Fri Sep 4 15:47 CST
🏠
🔍
04-Sep-2026
55.79
-0.70 {-1.2 %}
V: 893,726
CRSP
04-Sep-2026
Close: 55.79
-0.70 {-1.2 %}
Volume: 893,726
17-Aug-2026
29-May-2026
30-Sep-2025
31-Mar-2023
CRSP
SPY
-1.2
-3.3
-2.1
2.3
6.4
-0.4
0.1
0.4
3.1
12.9
% Price Gain
WTD Performance (%)
MTD Performance (%)
QTD Performance (%)
YTD Performance (%)
SPY tracks S&P 500 index.
15 minute intraday candlestick chart, ~15 minute delay
15 minute intraday candlestick chart, ~15 minute delay
CRSP News
5-Sep-2026 - Seeking AlphaCRISPR Therapeutics: CASGEVY Validates The Platform, Strengthening The Acquisition Case CRISPR Therapeutics' current $5.6B market cap and $1.78B net cash position offer acquisition appeal. Click to know why CRSP ... 2-Sep-2026 - Yahoo FinanceCRISPR Therapeutics (CRSP) Stock Looks Fully Valued As CTX310 Data Impresses CRISPR Therapeutics stock has climbed in the shorter term but still carries a heavy five year loss, and current valuation ... 2-Sep-2026 - Yahoo FinanceWhy Is CRISPR Therapeutics (CRSP) Up 7.1% Since Last Earnings Report? CRISPR Therapeutics (CRSP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for ... 3-Aug-2026 - Yahoo FinanceCRISPR Therapeutics AG (CRSP) Reports Q2 Loss, Tops Revenue Estimates CRISPR Therapeutics (CRSP) delivered earnings and revenue surprises of +14.55% and +37.28%, respectively, for the quarter ... 27-Jul-2026 - Yahoo FinanceCRISPR Therapeutics AG (CRSP) Expected to Beat Earnings Estimates: Can the Stock Move Higher? CRISPR Therapeutics (CRSP) possesses the right combination of the two key ingredients for a likely earnings beat in its ... 22-Jul-2026 - The Globe and MailCrispr Therapeutics AG (CRSP) Receives a Hold from Goldman Sachs In a report released yesterday, from Goldman Sachs maintained a Hold rating on Crispr Therapeutics AG, with a price target of $48.00. The company’s shares closed today at $46.99. Unlock powerful ... 20-Jul-2026 - Seeking AlphaCrispr Therapeutics: A Catalyst-Rich 12 Months Ahead CRISPR Therapeutics offers a diversified gene-editing pipeline, with CASGEVY as its lead asset and multiple upcoming ... 17-Jul-2026 - Yahoo FinanceCRISPR Therapeutics (CRSP) Slides For Six Days, Is The Stock Now Cheap? CRISPR Therapeutics (NasdaqGM:CRSP) has come under pressure after a six day losing streak that cut the stock by about 18%, ... 7-Jul-2026 - Yahoo FinanceCRISPR Therapeutics vs. Viking Therapeutics: Is a Gene-Editing or Weight Loss Focused Stock Is a Better Buy in 2026? One has FDA approval and revenue; the other is pre-commercial but debt-free. Both face distinct risks that could reshape your ...
More CRSP News
Disclaimer
Privacy
Contact
Copyright © 2001-2026, All rights reserved. HotCandlestick.com, LLC